Navigation Links
University of Maryland School of Medicine, NIH study pinpoints brain area's role in learning
Date:11/26/2012

An area of the brain called the orbitofrontal cortex is responsible for decisions made on the spur of the moment, but not those made based on prior experience or habit, according to a new basic science study from substance abuse researchers at the University of Maryland School of Medicine and the National Institute on Drug Abuse (NIDA). Scientists had previously believed that the area of the brain was responsible for both types of behavior and decision-making. The distinction is critical to understanding the neurobiology of decision-making, particularly with regard to substance abuse. The study was published online in the journal Science.

Scientists have assumed that the orbitofrontal cortex plays a role in "value-based" decision-making, when a person compares options and weights consequences and rewards to choose best alternative. The Science study shows that this area of the brain is involved in decision-making only when the value must be inferred or computed rapidly or hastily. If the value has been "cached" or pre-computed, like a habit, then the orbitofrontal cortex is not necessary.

The same is true for learning if a person infers an outcome but it does not happen, the resulting error can drive learning. The study shows that the orbitofrontal cortex is necessary for the inferred value that is used for this type of learning.

"Our research showed that damage to the orbitofrontal cortex may decrease a person's ability to use prior experience to make good decisions on the fly," says lead author Joshua Jones, Ph.D., a postdoctoral researcher at the University of Maryland School of Medicine and a research scientist at NIDA, part of the National Institutes of Health. "The person isn't able to consider the whole continuum of the decision the mind's map of how choices play out further down the road. Instead, the person is going to regress to habitual behavior, gravitating toward the choice that provides the most value in its immediate reward."

The study enhances scientists' understanding of how the brain works in healthy and unhealthy individuals, according to the researchers.

"This discovery has general implications in understanding how the brain processes information to help us make good decisions and to learn from our mistakes," says senior author Geoffrey Schoenbaum, M.D., Ph.D., adjunct professor at the University of Maryland School of Medicine and senior investigator and chief of the Cellular Neurobiology Research Branch at NIDA. "Understanding more about the orbitofrontal cortex also is important for understanding disorders such as addiction that seem to involve maladaptive decision-making and learning. Cocaine in particular seems to have long-lasting effects on the orbitofrontal cortex. One aspect of this work, which we are pursuing, is that perhaps some of the problems that characterize addiction are the result of drug-induced changes in this area of the brain."

The scientists are continuing their research, examining the specific coding of the neurons in the orbitofrontal cortex during this process, as well as the effects that drugs of abuse have upon this area of the brain.

"Drug addiction is marked by severe deficits in judgment and bad decision-making on the part of the addict," says Dr. Jones. "We believe that drugs, particularly cocaine, affect the orbitofrontal cortex. They coerce the system and hijack decision-making."

The researchers examined the orbitofrontal cortex's role in value-guided behavior. The brain assigns two different types of values to behaviors and choices. Cached value is a value that is learned during prior experience. Inferred value happens on the spur of the moment, considering the entire model of rewards and consequences.

"Cached value is stored during prior experience, says Dr. Jones. "For example, you learn your route home on your commute through experience the habit of how you get home. You turn right, go left, make another right. Inferred values, however, are based on estimating goals and values on the fly using your knowledge of the entire structure of the environment. For example, instead of just habitually going home on your usual route, you have the full map in your mind of all the roads that you use. You can adjust your route, making different turns, depending on the time of day or the amount of traffic. These inferred decisions are adaptive much more flexible based on the situation."

The scientists used a rat model for their research, disabling the orbitofrontal cortex and measuring the difference in behavior that resulted. Further study using the same rat model work not reported in this paper has shown that cocaine use mimics this damage to the orbitofrontal cortex.

Further study of this neurobiological mechanism is needed, and the results have not been replicated in humans, but certainly the research is promising, says E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs at the University of Maryland and John Z. and Akiko K. Bowers Distinguished Professor and dean at the University of Maryland School of Medicine. "Our goal here at the School of Medicine is to make groundbreaking discoveries in the laboratory that can be translated into new treatments and new hope for patients and their families," says Dean Reece. "We are hopeful that research tells us more about the basic mechanisms in the brain will translate to new techniques in neurobiology and in treating devastating conditions such as drug addiction."


'/>"/>

Contact: Karen Robinson
karobinson@som.umaryland.edu
410-706-7590
University of Maryland Medical Center
Source:Eurekalert

Related biology news :

1. University of Michigan, Michigan State University award grants for Great Lakes climate change research
2. Undersea gas leaks off Israels coast are discovered by University of Haifa researchers
3. Ben-Gurion University team in prestigious DARPA Robotics Challenge to develop disaster response robot
4. Israels first Green Roofs Ecology research center dedicated at University of Haifa
5. Louisiana Tech University professor earns national honor from Society of American Foresters
6. High-strength material advancements at Wayne State University may lead to new, life-saving steel
7. Baylor University scientist receives major grants for health research on 1991 Gulf War veterans
8. University of Toronto study demonstrates impact of adversity on early life development
9. The George Washington University Researcher received $1.7 million to study solar cement
10. The 2013 HFSP Nakasone Award goes to Stephen Quake of Stanford University
11. University of Tennessee, ORNL lead national team to study nuclear fusion reactors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: